Clinical trial
Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With…
NCT00199186 · Johann Wolfgang Goethe University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00199186 |
|---|---|
| Title | Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) |
| Official title | A Randomized, Multicenter Open Label Phase II Study to Determine the Safety and Efficacy of Induction Therapy With Imatinib in Comparison With Standard Induction Chemotherapy in Elderly (> 55 Years) Patients With Ph Positive Acute Lymphoblastic Leukemia (ALL) |
| Lead sponsor | Johann Wolfgang Goethe University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Philadelphia Positive Acute Lymphoblastic Leukemia, Lymphoid Blastic Phase of Chronic Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | imatinib, vincristine, cyclophosphamide, cytosine arabinoside, dexamethasone, idarubicin, methotrexate (intrathecal), AraC (intrathecal), dexamethasone (intrathecal) |
| Start date | Mar 1, 2002 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 19, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: